Portfolio Complexity Management

𝗧𝗵𝗲 €𝟰𝟱𝟬𝗠 𝗦𝗵𝗿𝗶𝗻𝗸 𝘁𝗼 𝗚𝗿𝗼𝘄 𝗣𝗹𝗮𝘆𝗯𝗼𝗼𝗸: 𝟱 𝗤𝘂𝗲𝘀𝘁𝗶𝗼𝗻𝘀 𝗘𝘃𝗲𝗿𝘆 𝗙𝗠𝗖𝗚 𝗖𝗘𝗢 𝗠𝘂𝘀𝘁 𝗔𝗻𝘀𝘄𝗲𝗿 𝗡𝗢𝗪 Is Shrink to Grow helping? Campari just killed 30 brands. Stock up 27%. Coincidence? No. → €450M revenue sacrificed. → Margins jumping 200 bps. → Debt dropping to 2.5x EBITDA. More and more FMCG execs call me. Exact question: "Should we copy Campari?" Wrong question. Ask these five instead: 𝗤𝟭: 𝗪𝗵𝗶𝗰𝗵 𝗯𝗿𝗮𝗻𝗱𝘀 𝗮𝗿𝗲 𝗯𝗹𝗲𝗲𝗱𝗶𝗻𝗴 𝘆𝗼𝘂 𝗱𝗿𝘆? ↳ Bottom 30% of portfolio = 43% of complexity. ↳ Complexity kills margins faster than competition. ↳ If the margin is < 40% and growth is < 3%, it's dead weight. ↳ Can these brands release A&P to global priorities? 𝗤𝟮: 𝗖𝗮𝗻 𝘆𝗼𝘂 𝗮𝗳𝗳𝗼𝗿𝗱 𝘆𝗼𝘂𝗿 𝗱𝗲𝗯𝘁 𝗶𝗻 𝟮𝟬𝟮𝟲? ↳ Markets hate leverage above 4x. Period. ↳ Rising rates + high debt = death spiral. ↳ Campari went from 3.2x to 2.5x. Are you next? 𝗤𝟯: 𝗗𝗼 𝘆𝗼𝘂 𝗼𝘄𝗻 𝘆𝗼𝘂𝗿 𝗰𝗮𝘁𝗲𝗴𝗼𝗿𝘆 𝗼𝗿 𝗷𝘂𝘀𝘁 𝗽𝗹𝗮𝘆 𝗶𝗻 𝗶𝘁? ↳ Global priorities should = 65%+ of revenue. ↳ How High is your Right to Win? ↳ Everything else? Expensive distraction. ↳ Focus beats portfolio breadth. Every time. ↳ Be mindful of mid-term competitive gaps. 𝗤𝟰: 𝗪𝗵𝗮𝘁'𝘀 𝘆𝗼𝘂𝗿 𝗿𝗲𝗮𝗹 𝗰𝗼𝘀𝘁 𝗼𝗳 𝗰𝗼𝗺𝗽𝗹𝗲𝘅𝗶𝘁𝘆? ↳ Supply chain fragmentation. ↳ Marketing budget dilution. ↳ Management attention scatter. ↳ Calculate it. Then double it. That's reality. 𝗤𝟱: 𝗪𝗵𝗼'𝘀 𝗯𝘂𝘆𝗶𝗻𝗴 𝘆𝗼𝘂𝗿 𝘇𝗼𝗺𝗯𝗶𝗲𝘀? ↳ Private equity loves orphan brands. ↳ Regional players need portfolio depth. ↳ Your trash = someone's treasure. ↳ But only if you move NOW. 𝗧𝗵𝗲 𝗵𝗮𝗿𝗱 𝘁𝗿𝘂𝘁𝗵: Portfolio pruning isn't a retreat. It's a strategy. Campari proved it. Henkel's doing it. Unilever too. Reckitt, Diageo, Pernod Ricard, Edgewell, the list goes on. The inflation party ended. Volume growth is king. Complexity is your enemy. Focus and clarity are you best friends. Many acquisitions built the Campari portfolio and its success But also its bloat. Thirty divestitures will reshape their future. Net margin target: 6.1% → 13.6% by 2027. That's not improvement. That's transformation. Your portfolio is your prison. Every brand you keep is a choice. Choose focus. Choose margins. Choose survival. 𝗜𝗳 𝘆𝗼𝘂'𝗿𝗲 𝗿𝘂𝗻𝗻𝗶𝗻𝗴 𝗮𝗻 𝗙𝗠𝗖𝗚 𝗯𝗿𝗮𝗻𝗱 𝗼𝗿 𝗮𝗱𝘃𝗶𝘀𝗶𝗻𝗴 𝗼𝗻𝗲: Answer these five questions. Today. Can't answer? Your competitors already have. DM me. We'll build your Shrink-to-Grow playbook together. ___________ 👋 Hi, I am Filiberto. Follow me for sharp FMCG strategic insights. If you like this post, you are going to love my newsletter: https://lnkd.in/dFwbrjwG

If your investing strategy feels exciting… You’re probably doing it wrong. The best investors in the world know something most people overlook: Complexity is not sophistication. It’s sabotage. Morgan Housel, author of The Psychology of Money, warns that many smart people “try to make investing as complicated as they possibly can.” The result? - Worse performance - More stress - Constant second-guessing The more complicated your investment strategy, the harder it is to stick with it when markets get rough. Complex portfolios can lead to: 🚫 Overtrading 🚫 Higher fees 🚫 Emotional decision-making 🚫 Missed opportunities due to hesitation BEST ADVICE Make your strategy as brainless, simple, and boring as possible. It’s not about finding the hottest stock or the most exotic asset class. It’s about time. “If you can be an average investor for an above-average period of time… you’ll do amazing.” – Morgan Housel In other words: Consistency beats complexity. If you can stick with a simple, well-structured plan for 20, 30, even 50 years, you’re likely to outperform most people chasing the “next big thing.” The Tool That Makes It Simple Low-cost index funds (like VOO or VTI) Track broad market indexes such as the S&P 500. Index Funds (or ETFs) give you: ✅ Diversification – Exposure to hundreds of companies at once ✅ Market Matching – Capture the long-term upward trend of the market ✅ Low Cost – Minimal fees, meaning more of your returns stay with you Only 7% of active fund managers beat their passive rivals from 2015–2024 (Morningstar). The odds are not in your favor if you try to outsmart the market. Warren Buffett has been saying it for decades: “By periodically investing in an index fund… the know-nothing investor can actually outperform most investment professionals.” If one of the most successful investors alive says index funds are the right choice for most people, it’s worth listening. Housel flips the traditional investor mindset on its head: ❓ The question isn’t “What are the highest returns I can earn?” ❓ It’s “What returns can I keep earning for the longest period of time?” That’s why simple, repeatable strategies usually win. They’re easier to stick with through good markets and bad. The Simple Strategy for Most Investors 1️⃣ Own a diversified portfolio of low-cost index funds. 2️⃣ Add to it regularly. 3️⃣ Hold for as long as possible (decades, not months). It’s not exciting, and it’s not flashy. But it works. Bottom line: Investing isn’t about constant action, It’s about disciplined inaction. Avoid the complexity trap. Keep your portfolio simple. Stay consistent for the long haul. The smartest investors don’t chase adrenaline. They chase outcomes. ❓ What’s your approach, complex or simple? ♻️ Repost to help others avoid the complexity trap ➕ Follow me here on LinkedIn for more straightforward, results-focused investing insights.

𝐓𝐡𝐞 𝐧𝐞𝐱𝐭 𝐰𝐚𝐯𝐞 𝐨𝐟 𝐯𝐚𝐥𝐮𝐞 𝐜𝐫𝐞𝐚𝐭𝐢𝐨𝐧 𝐦𝐚𝐲 𝐧𝐨𝐭 𝐜𝐨𝐦𝐞 𝐟𝐫𝐨𝐦 𝐚𝐝𝐝𝐢𝐧𝐠 𝐦𝐨𝐫𝐞—𝐢𝐭 𝐰𝐢𝐥𝐥 𝐜𝐨𝐦𝐞 𝐟𝐫𝐨𝐦 𝐟𝐨𝐜𝐮𝐬𝐢𝐧𝐠 𝐛𝐞𝐭𝐭𝐞𝐫. The companies unlocking the most shareholder value right now are those rethinking where and how their capital works hardest. Recent corporate announcements show that breaking up isn’t about fixing past missteps. It’s a forward-looking move to sharpen focus, simplify governance, and amplify growth. For many diversified firms, complexity has become a drag on valuation, decision-making, and capital deployment. From my experience leading through major capital reallocation transactions, I’ve seen the benefits firsthand. Creating pure-play entities with sufficient scale isn’t just about appeasing markets. It clarifies strategy, streamlines execution, and opens the door to focused capital allocation. What separates proactive companies from reactive ones is timing. Too often, boards wait for external pressure to call out misalignment. By then, they’re defending decisions instead of defining them. By contrast, companies that run a disciplined and recurring portfolio review process can identify high-growth, high-multiple segments early, and move before the market forces their hand. We’re now in an era where capital intensity, geopolitical volatility, and technological disruption all reward simplicity and focus. That means capital allocation must evolve too. Boards today should ask: - Are we organized for strategic clarity or burdened by legacy complexity? - Is our capital allocation process designed for today’s market realities or built on legacy structure? - Do we have the right governance in place to model, track, and communicate the impact of structural change? Proactive portfolio transformation isn’t just good defense. It’s a forward-looking move that positions companies for resilience and relevance in a dynamic market. Is your capital truly working where it creates the most value? #CapitalAllocation #BoardLeadership #StrategicValueCreation

A DTC primary care company was scaling across multiple states. Fast growth. Strong patient satisfaction scores. Everything looked good on paper. Except the operations team was drowning. Care Coordination was buried under accumulated policies and processes. Each policy made sense when created. Written to solve a real problem. Approved by thoughtful people. Collectively, they created gridlock. The team couldn't serve more patients without adding headcount. Response times were slipping. The 10-minute standard was becoming 15, then 20 minutes. The executive team's instinct? Buy more sophisticated care management software. Hire more coordinators. But the data told a different story. The problem wasn't tools or people. It was policy proliferation. Well-intentioned complexity that had accumulated over three years of growth. The solution? Simplification. We didn't add systems. We removed friction. Streamlined policies. Redesigned processes to match the actual work, not the theoretical workflow someone had drawn on a whiteboard two years prior. Results within 90 days: → Served 25% more patients → No headcount increase → Maintained 10-minute response time → Reduced clinician licensing costs by 64% through policy redesign alone Here's what the data shows across every mid-market company I work with: Between $10M and $500M in revenue, complexity accumulates faster than companies can execute efficiently. What costs you 2 points of margin today will cost you 5 points in three years if unaddressed. The Complexity Tax compounds. But here's the counterintuitive truth: you don't need more resources to fix it. You need different focus. Strategy → Policies → Data-Enabled Workflows → Technology and People That's the sequence. Most companies start with technology and people. But if strategy and policies are misaligned with operational reality, better technology just automates complexity faster. I've identified five sources where the Complexity Tax bleeds margin: → Product proliferation without portfolio discipline → Policy-process misalignment → Tech stack bloat → Decision rights ambiguity → The exception that became the rule Each one has diagnostic questions to help you identify where you're paying the tax. Want to see where your company stands? Take the 5-minute self-assessment and read the full framework with case studies: https://lnkd.in/edu2pgQ4

A fund admin handles a PE fund with 12 companies. Then they onboard a VC fund with 40. Similar fees, different workload. The VC complexity is the: 1. volume 2. instrument variety One portfolio company might have: - A SAFE from the seed round - Another SAFE with a different cap from the bridge - Series A preferred - A convertible note accruing interest Each converts differently, at different times, under different terms. And SAFEs aren't debt or equity until a priced round, if one never happens. They sit in accounting limbo. About 90% of pre-seed rounds use them now. 3 things that trip up admins new to VC: QSBS tracking - LPs can exclude gains from taxes if stock is held long enough, but with SAFEs it's unclear when the clock starts. The IRS hasn't settled it. Track both dates. Pro rata rights - used to be built into the SAFE. Since 2018 they often live in side letters. Every new round can mean digging through side letters for 40+ companies. Valuation subjectivity - PE funds can value companies with revenue and EBITDA. VC admins value pre-revenue companies with no financial history. More judgment, more GP input, more back-and-forth.

Your OTIF problem isn’t the warehouse. It starts in the product portfolio. Every time a company calls me about service issues, the first suspects are the same: “The warehouse layout is wrong.” “Pickers are too slow.” “We need a better WMS.” Sometimes that’s true — but usually, it’s not. One discrete manufacturer I worked with was stuck at 82% OTIF. They re-slotted the warehouse, installed a new WMS, optimized pick paths. Nothing moved. So we did something unpopular: We stopped looking at the warehouse and looked at the catalogue. What we found was brutal: 8,000+ SKUs Near-duplicates Custom variants sold twice a year “Strategic” SKUs no one could justify On paper: “customer choice.” In reality: operational roulette. Fast movers were short because capacity was eaten by exotic, low-volume items. Safety stocks spread too thin. One bad forecast on a tiny SKU created noise everywhere. The warehouse was just where the pain showed up. We reframed it: “We don’t have a logistics issue. We have a promise issue.” Then we changed three things: 1️⃣ Ruthless SKU segmentation We grouped SKUs: • Workhorse: high volume, high margin, must-win • Enabler: needed, but not stars • Vanity: low volume, low margin, high complexity For each we defined service promise, planning, inventory approach. We asked: “If this SKU vanished tomorrow, who would scream — and would it matter?” Dozens vanished. Only planners noticed — finally some breathing room. 2️⃣ A real A-list for availability A-list SKUs were: • Always available • Protected capacity • Clear minimum stock Everything else: “best effort,” transparent lead time. No heroics that damage the A-list. Sales got a script: “If you want speed, sell from here.” The plant got a spine: “If we must choose, we choose the A-list.” Warehouse improved without touching a rack — flow finally made sense. 3️⃣ Portfolio decisions before process improvements Instead of “How do we handle all this complexity better?” we asked: “Which complexity should we stop handling?” Only then did we revisit slotting, pick paths, waves — and it stuck. Within 6 months: ✅ A-list OTIF: 82% → 94% ✅ Fewer expedites on low-value SKUs ✅ Warehouse mindset shifted to “We know what matters” Same people. Same building. Same WMS. The difference? Service became a strategic choice — not a warehouse sport. If you’re staring at bad OTIF numbers, don’t start with tech or more labor. Start with one honest workshop: Put your SKU list on the wall. Mark what drives profit and what drives complexity. Decide what can be “good enough” so your winners can be great. Because you don’t fix OTIF where the truck leaves the gate. You fix it where the promise is made. ♺ Reshare this — your Commercial, Ops, and Supply Chain leaders need this conversation. ► For more no-BS manufacturing and Supply Chain transformation stories: Join the newsletter → https://lnkd.in/dMGaUj4p

Is your large-scale Financial Service (BFSI) ADM contract designed to fail? The complexity of a Financial Institution's application portfolio is the "dirty secret" of every outsourcing deal. Most leaders think they are managing a single IT estate; in reality, they are managing a multi-layered Technical-Debt Ecosystem. A simple "lift-and-shift" won't cut it in 2025. Survival requires a surgical, data-driven strategy that separates Core Value from Technical Debt. I’ve broken down the 4 Pillars of a Modern ADM Portfolio that define the true cost and potential of every $100M+ engagement: 1️⃣ Core Financial Applications (The "Crown Jewels") 🔺Order Management Systems (OMS), Global Custody Platforms, Risk & Compliance Engines. The ADM Goal: Stability & AI Modernization. Focus on "API-fication" and moving to cloud-native architectures so mission-critical systems can integrate with modern AI without compromising security. The True KPI: Latency & Regulatory Compliance. Success means zero-incident performance and real-time adherence to shifting global standards. 2️⃣ ERP & Support Systems (The "Commodities") 🔺SAP S/4HANA, Workday, Oracle HCM, ServiceNow. The ADM Goal: Industrialization & Automation. These are standardized processes where providers must drive "Shift-Left" models and hyper-automation to eliminate manual intervention. The True KPI: Cost-to-Serve. The ultimate metric is the lowest possible price per ticket/transaction through scale. 3️⃣ Legacy & Long-Tail (The "Technical Debt Tsunami") 🔺Custom Access databases, Mainframe (COBOL), aging Visual Basic apps. The ADM Goal: Rationalization (The R3 Strategy). Every dollar spent here is "keeping the lights on" for inefficient code. The goal is to Retire, Rewrite, or Replatform. The True KPI: Application Tally Reduction. Success is measured by the percentage of the portfolio decommissioned or migrated each year. 4️⃣ Digital & Emerging Tech (The "Future of Reinvention") 🔺 Customer Mobile Apps, MLOps Pipelines, AI-powered Fraud Detection. The ADM Goal: Agile Development. Utilizing DevOps and MLOps to support a high rate of change. This is where the business innovates and scales new AI-driven capabilities. The True KPI: Feature Velocity. How fast can a new digital feature or AI model move from concept to a live environment? The Tholons Inc. Take: In the "Generative Enterprise" era, success is measured by how fast you move apps from Bucket 3 (Debt) to Bucket 4 (Value) without destabilizing Bucket 1 (Core). We are shifting from labor arbitrage to IP-arbitrage and AI-Productivity. The provider that wins the next decade is the one that moves the conversation from "How many people will you use?" to "How many applications can you kill, and how fast can you modernize the rest with Agentic AI?" The legacy ADM model is officially Technical Debt. The new model is AI-Driven Reinvention. #AI #GenerativeAI #GCC #ITServices #ApplicationDevelopment #Fintech Frank Pendle Ankita Vashistha Avnish Sabharwal

Animal health is leaving a frightening amount of value on the table by treating products like pets instead of a portfolio. Most companies still “add one more SKU” or “buy the shiny thing” without designing how the whole portfolio composes into outsized, leveraged returns. Buying and selling company assets and products just hit the big time. Treat it like a market, not a museum. Modern portfolio theory for products is not academic. It is operating math. When you design a portfolio, you stop chasing orphan wins and start compounding system effects. A few moves that separate the leaders from the collectors: —Build to a yield curve. Balance near-cash generators, mid-risk growers, and long-dated options so shared costs and channels get cheaper per dollar over time. —Buy only where your platform multiplies value. Sell where you are a tourist. If it does not increase cross-sell, data gravity, or capacity utilization, it is inventory, not strategy. —Create synthetic returns. Royalty stacks, milestone swaps, co-promotes, and out-licenses that turn non-core science into cash flow while preserving upside. —Make the portfolio P&L explicit. Track the lift from shared sales force, manufacturing headroom, service lines, and data products. If the product does not improve the portfolio P&L, you are subsidizing it. —Enforce kill discipline. Cut assets that do not improve the whole. Rebalance quarterly. Treat features like options and prune the ones you would not buy today. —Design channels as assets. Own at least one route where you control pricing, data, and customer relationship, then let partners rent access. Animal health can do this today. Companion, production, diagnostics, software, services, and therapeutics become a designed stack that throws off cash, insights, and optionality. Human biotech and pharma benefit from the exact same calculus, especially as pipelines get modular and tradable. This is not M&A theater. This is portfolio design that turns science, channels, and contracts into a compounding machine. If your roadmap reads like a shopping list, you are donating returns to the competitor who treats their portfolio like a fund. Time to reward active portfolio design. #AnimalHealth #Biotech #Pharma #PortfolioStrategy #CapitalAllocation #ProductStrategy #CorporateStrategy #MergersAndAcquisitions #LifeSciences #VeterinaryMedicine #GoToMarket #RAndD #Licensing #Valuation

Complexity beats simplification in beauty; that's L'Oreal's masterclass. And they make it look so easy. While we're crunching the numbers and gathering more input for 2025, here's a holiday treat from our team: some headlines from our growth playbook. 💡L'Oréal has achieved what most CPG brands aspire to: 7X growth over 30 years, $47B in revenue in beauty (76% larger than Unilever), and category dominance representing 33% of the Top 8 global cosmetics market ($141.2B). The playbook summary below synthesizes L'Oréal's proven strategy with emerging competitive dynamics. 𝗣𝗜𝗟𝗟𝗔𝗥 𝟭: Portfolio Architecture & M&A Mastery Your Strategic Principle: Complexity as a competitive advantage through strategic optionality at scale You need to build a portfolio across all price tiers, no exception. 1. Mass Market (Volume drivers): Maybelline, L'Oréal Paris, Garnier 2. Professional (B2B + loyalty): Matrix, Kérastase, Redken, ColorWow 3. Active Cosmetics/Dermocosmetics (Medical credibility): La Roche-Posay, CeraVe, SkinCeuticals, Vichy 4. Luxury (Margin maximizers): YSL, Lancôme, Kiehl's, Urban Decay, now Creed + Gucci/Balenciaga licenses Each tier serves different channels, price sensitivities, and consumer occasions—creating portfolio resilience against market volatility. 𝗣𝗜𝗟𝗟𝗔𝗥 𝟮: Channel-Specific Optimization - Cerave dominates Amazon 1P - Lancôme owns Sephora counters - Kérastase Paris leads salon professional - La Roche-Posay USA controls pharmacy 𝗣𝗜𝗟𝗟𝗔𝗥 𝟯: Retail media leadership will give you wings, so you should implement category-leading retail media investment. 2025 Benchmarks (Beauty & Personal Care) from ecommert Navigator Global Retail Media Benchmark Allocations Report (you can find it in the comments) 👇 - 22.7% of total ad spend (US: 23-27%, EU: 18%) - 2.35% of net revenue on average - $6.60+ ROAS when executed well 💡Beauty leads ALL #FMCG categories in retail media maturity—treating it as core infrastructure, not experimental spend. 𝗣𝗜𝗟𝗟𝗔𝗥 𝟰: You must master consumer behavior and data-driven personalization. Step 1: Build the first-party data ecosystem to capture first-party data from minimum 30%+ of your consumers within 18 months. Step 2: Leverage AI for hyper-personalization, use LLM beauty assistants, predictive replenishment and launch conversational product discovery. Step 3: You'd better master the "Niche-to-Mainstream" funnel 🚨Old Model: Mass production → broad distribution → heavy discounting 💡New Model: Limited drops → atelier collabs → data-driven micro-batches → TikTok → Duty Free (in weeks, not quarters) 𝗣𝗜𝗟𝗟𝗔𝗥 𝟱: Digital excellence requires robust organizational design, so revamp your org. Investment benchmark: Winners invest >10% of revenues in digital technologies and #eCommerce. Size doesn't guarantee growth; omnichannel execution + retail media optimization does. More to come, stay tuned. #FMCG #Beauty #Growth #Strategy